Global Antisense Oligonucleotides-based Therapeutics Supply, Demand and Key Producers, 2023-2029
The global Antisense Oligonucleotides-based Therapeutics market size is expected to reach $ 9669.6 million by 2029, rising at a market growth of 16.6% CAGR during the forecast period (2023-2029).
The Antisense Oligonucleotide (ASO) Market is driven by the promising potential of ASOs in treating genetic disorders, rare diseases, and certain cancers by targeting specific RNA molecules and inhibiting their expression. ASOs represent a groundbreaking therapeutic approach that offers the possibility of highly targeted and personalized treatments. As our understanding of genomics and molecular biology advances, and precision medicine gains momentum, the demand for ASOs continues to grow. Innovations in ASO design, chemical modifications, and delivery technologies further contribute to market expansion. However, a significant challenge for this market is the need to address effective delivery to the target tissues, ensure long-term safety and efficacy, and navigate complex regulatory pathways. Overcoming delivery hurdles, minimizing off-target effects, and managing high development costs are ongoing challenges. Additionally, the market faces competition from traditional therapeutic approaches and the need for continuous research and development to fully unlock the therapeutic potential of ASOs. Striking a balance between providing safe, effective, and accessible ASO therapies while addressing scientific and regulatory challenges is essential for the continued growth of the Antisense Oligonucleotide (ASO) Market.
Antisense Oligonucleotides (ASOs) are a class of nucleic acid drugs designed to target specific RNA molecules within cells. They work by binding to complementary RNA sequences, which can modulate gene expression in various ways. ASOs have been developed to treat a wide range of genetic and other diseases.
This report studies the global Antisense Oligonucleotides-based Therapeutics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Antisense Oligonucleotides-based Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antisense Oligonucleotides-based Therapeutics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Antisense Oligonucleotides-based Therapeutics total market, 2018-2029, (USD Million)
Global Antisense Oligonucleotides-based Therapeutics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Antisense Oligonucleotides-based Therapeutics total market, key domestic companies and share, (USD Million)
Global Antisense Oligonucleotides-based Therapeutics revenue by player and market share 2018-2023, (USD Million)
Global Antisense Oligonucleotides-based Therapeutics total market by Type, CAGR, 2018-2029, (USD Million)
Global Antisense Oligonucleotides-based Therapeutics total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Antisense Oligonucleotides-based Therapeutics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sarepta Therapeutics, Ionis Pharmaceuticals, Biogen, Nippon Shinyaku, Sobi and Jazz Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antisense Oligonucleotides-based Therapeutics market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Antisense Oligonucleotides-based Therapeutics Market, By Region:
1. How big is the global Antisense Oligonucleotides-based Therapeutics market?
2. What is the demand of the global Antisense Oligonucleotides-based Therapeutics market?
3. What is the year over year growth of the global Antisense Oligonucleotides-based Therapeutics market?
4. What is the total value of the global Antisense Oligonucleotides-based Therapeutics market?
5. Who are the major players in the global Antisense Oligonucleotides-based Therapeutics market?
The Antisense Oligonucleotide (ASO) Market is driven by the promising potential of ASOs in treating genetic disorders, rare diseases, and certain cancers by targeting specific RNA molecules and inhibiting their expression. ASOs represent a groundbreaking therapeutic approach that offers the possibility of highly targeted and personalized treatments. As our understanding of genomics and molecular biology advances, and precision medicine gains momentum, the demand for ASOs continues to grow. Innovations in ASO design, chemical modifications, and delivery technologies further contribute to market expansion. However, a significant challenge for this market is the need to address effective delivery to the target tissues, ensure long-term safety and efficacy, and navigate complex regulatory pathways. Overcoming delivery hurdles, minimizing off-target effects, and managing high development costs are ongoing challenges. Additionally, the market faces competition from traditional therapeutic approaches and the need for continuous research and development to fully unlock the therapeutic potential of ASOs. Striking a balance between providing safe, effective, and accessible ASO therapies while addressing scientific and regulatory challenges is essential for the continued growth of the Antisense Oligonucleotide (ASO) Market.
Antisense Oligonucleotides (ASOs) are a class of nucleic acid drugs designed to target specific RNA molecules within cells. They work by binding to complementary RNA sequences, which can modulate gene expression in various ways. ASOs have been developed to treat a wide range of genetic and other diseases.
This report studies the global Antisense Oligonucleotides-based Therapeutics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Antisense Oligonucleotides-based Therapeutics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antisense Oligonucleotides-based Therapeutics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Antisense Oligonucleotides-based Therapeutics total market, 2018-2029, (USD Million)
Global Antisense Oligonucleotides-based Therapeutics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Antisense Oligonucleotides-based Therapeutics total market, key domestic companies and share, (USD Million)
Global Antisense Oligonucleotides-based Therapeutics revenue by player and market share 2018-2023, (USD Million)
Global Antisense Oligonucleotides-based Therapeutics total market by Type, CAGR, 2018-2029, (USD Million)
Global Antisense Oligonucleotides-based Therapeutics total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Antisense Oligonucleotides-based Therapeutics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sarepta Therapeutics, Ionis Pharmaceuticals, Biogen, Nippon Shinyaku, Sobi and Jazz Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antisense Oligonucleotides-based Therapeutics market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Antisense Oligonucleotides-based Therapeutics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- With Chemical Modification
- Without Chemical Modification
- Neuromuscular Diseases
- hATTR
- Other
- Sarepta Therapeutics
- Ionis Pharmaceuticals
- Biogen
- Nippon Shinyaku
- Sobi
- Jazz Pharmaceuticals
1. How big is the global Antisense Oligonucleotides-based Therapeutics market?
2. What is the demand of the global Antisense Oligonucleotides-based Therapeutics market?
3. What is the year over year growth of the global Antisense Oligonucleotides-based Therapeutics market?
4. What is the total value of the global Antisense Oligonucleotides-based Therapeutics market?
5. Who are the major players in the global Antisense Oligonucleotides-based Therapeutics market?
1 SUPPLY SUMMARY
1.1 Antisense Oligonucleotides-based Therapeutics Introduction
1.2 World Antisense Oligonucleotides-based Therapeutics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Antisense Oligonucleotides-based Therapeutics Total Market by Region (by Headquarter Location)
1.3.1 World Antisense Oligonucleotides-based Therapeutics Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Antisense Oligonucleotides-based Therapeutics Market Size (2018-2029)
1.3.3 China Antisense Oligonucleotides-based Therapeutics Market Size (2018-2029)
1.3.4 Europe Antisense Oligonucleotides-based Therapeutics Market Size (2018-2029)
1.3.5 Japan Antisense Oligonucleotides-based Therapeutics Market Size (2018-2029)
1.3.6 South Korea Antisense Oligonucleotides-based Therapeutics Market Size (2018-2029)
1.3.7 ASEAN Antisense Oligonucleotides-based Therapeutics Market Size (2018-2029)
1.3.8 India Antisense Oligonucleotides-based Therapeutics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Antisense Oligonucleotides-based Therapeutics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Antisense Oligonucleotides-based Therapeutics Major Market Trends
2 DEMAND SUMMARY
2.1 World Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029)
2.2 World Antisense Oligonucleotides-based Therapeutics Consumption Value by Region
2.2.1 World Antisense Oligonucleotides-based Therapeutics Consumption Value by Region (2018-2023)
2.2.2 World Antisense Oligonucleotides-based Therapeutics Consumption Value Forecast by Region (2024-2029)
2.3 United States Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029)
2.4 China Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029)
2.5 Europe Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029)
2.6 Japan Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029)
2.7 South Korea Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029)
2.8 ASEAN Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029)
2.9 India Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029)
3 WORLD ANTISENSE OLIGONUCLEOTIDES-BASED THERAPEUTICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Antisense Oligonucleotides-based Therapeutics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Antisense Oligonucleotides-based Therapeutics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Antisense Oligonucleotides-based Therapeutics in 2022
3.2.3 Global Concentration Ratios (CR8) for Antisense Oligonucleotides-based Therapeutics in 2022
3.3 Antisense Oligonucleotides-based Therapeutics Company Evaluation Quadrant
3.4 Antisense Oligonucleotides-based Therapeutics Market: Overall Company Footprint Analysis
3.4.1 Antisense Oligonucleotides-based Therapeutics Market: Region Footprint
3.4.2 Antisense Oligonucleotides-based Therapeutics Market: Company Product Type Footprint
3.4.3 Antisense Oligonucleotides-based Therapeutics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Antisense Oligonucleotides-based Therapeutics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Antisense Oligonucleotides-based Therapeutics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Antisense Oligonucleotides-based Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Antisense Oligonucleotides-based Therapeutics Consumption Value Comparison
4.2.1 United States VS China: Antisense Oligonucleotides-based Therapeutics Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Antisense Oligonucleotides-based Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Antisense Oligonucleotides-based Therapeutics Companies and Market Share, 2018-2023
4.3.1 United States Based Antisense Oligonucleotides-based Therapeutics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Antisense Oligonucleotides-based Therapeutics Revenue, (2018-2023)
4.4 China Based Companies Antisense Oligonucleotides-based Therapeutics Revenue and Market Share, 2018-2023
4.4.1 China Based Antisense Oligonucleotides-based Therapeutics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Antisense Oligonucleotides-based Therapeutics Revenue, (2018-2023)
4.5 Rest of World Based Antisense Oligonucleotides-based Therapeutics Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Antisense Oligonucleotides-based Therapeutics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Antisense Oligonucleotides-based Therapeutics Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Antisense Oligonucleotides-based Therapeutics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 With Chemical Modification
5.2.2 Without Chemical Modification
5.3 Market Segment by Type
5.3.1 World Antisense Oligonucleotides-based Therapeutics Market Size by Type (2018-2023)
5.3.2 World Antisense Oligonucleotides-based Therapeutics Market Size by Type (2024-2029)
5.3.3 World Antisense Oligonucleotides-based Therapeutics Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Antisense Oligonucleotides-based Therapeutics Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Neuromuscular Diseases
6.2.2 hATTR
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Antisense Oligonucleotides-based Therapeutics Market Size by Application (2018-2023)
6.3.2 World Antisense Oligonucleotides-based Therapeutics Market Size by Application (2024-2029)
6.3.3 World Antisense Oligonucleotides-based Therapeutics Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sarepta Therapeutics
7.1.1 Sarepta Therapeutics Details
7.1.2 Sarepta Therapeutics Major Business
7.1.3 Sarepta Therapeutics Antisense Oligonucleotides-based Therapeutics Product and Services
7.1.4 Sarepta Therapeutics Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Sarepta Therapeutics Recent Developments/Updates
7.1.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.2 Ionis Pharmaceuticals
7.2.1 Ionis Pharmaceuticals Details
7.2.2 Ionis Pharmaceuticals Major Business
7.2.3 Ionis Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Product and Services
7.2.4 Ionis Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Ionis Pharmaceuticals Recent Developments/Updates
7.2.6 Ionis Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Biogen
7.3.1 Biogen Details
7.3.2 Biogen Major Business
7.3.3 Biogen Antisense Oligonucleotides-based Therapeutics Product and Services
7.3.4 Biogen Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Biogen Recent Developments/Updates
7.3.6 Biogen Competitive Strengths & Weaknesses
7.4 Nippon Shinyaku
7.4.1 Nippon Shinyaku Details
7.4.2 Nippon Shinyaku Major Business
7.4.3 Nippon Shinyaku Antisense Oligonucleotides-based Therapeutics Product and Services
7.4.4 Nippon Shinyaku Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Nippon Shinyaku Recent Developments/Updates
7.4.6 Nippon Shinyaku Competitive Strengths & Weaknesses
7.5 Sobi
7.5.1 Sobi Details
7.5.2 Sobi Major Business
7.5.3 Sobi Antisense Oligonucleotides-based Therapeutics Product and Services
7.5.4 Sobi Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Sobi Recent Developments/Updates
7.5.6 Sobi Competitive Strengths & Weaknesses
7.6 Jazz Pharmaceuticals
7.6.1 Jazz Pharmaceuticals Details
7.6.2 Jazz Pharmaceuticals Major Business
7.6.3 Jazz Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Product and Services
7.6.4 Jazz Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Jazz Pharmaceuticals Recent Developments/Updates
7.6.6 Jazz Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Antisense Oligonucleotides-based Therapeutics Industry Chain
8.2 Antisense Oligonucleotides-based Therapeutics Upstream Analysis
8.3 Antisense Oligonucleotides-based Therapeutics Midstream Analysis
8.4 Antisense Oligonucleotides-based Therapeutics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Antisense Oligonucleotides-based Therapeutics Introduction
1.2 World Antisense Oligonucleotides-based Therapeutics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Antisense Oligonucleotides-based Therapeutics Total Market by Region (by Headquarter Location)
1.3.1 World Antisense Oligonucleotides-based Therapeutics Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Antisense Oligonucleotides-based Therapeutics Market Size (2018-2029)
1.3.3 China Antisense Oligonucleotides-based Therapeutics Market Size (2018-2029)
1.3.4 Europe Antisense Oligonucleotides-based Therapeutics Market Size (2018-2029)
1.3.5 Japan Antisense Oligonucleotides-based Therapeutics Market Size (2018-2029)
1.3.6 South Korea Antisense Oligonucleotides-based Therapeutics Market Size (2018-2029)
1.3.7 ASEAN Antisense Oligonucleotides-based Therapeutics Market Size (2018-2029)
1.3.8 India Antisense Oligonucleotides-based Therapeutics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Antisense Oligonucleotides-based Therapeutics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Antisense Oligonucleotides-based Therapeutics Major Market Trends
2 DEMAND SUMMARY
2.1 World Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029)
2.2 World Antisense Oligonucleotides-based Therapeutics Consumption Value by Region
2.2.1 World Antisense Oligonucleotides-based Therapeutics Consumption Value by Region (2018-2023)
2.2.2 World Antisense Oligonucleotides-based Therapeutics Consumption Value Forecast by Region (2024-2029)
2.3 United States Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029)
2.4 China Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029)
2.5 Europe Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029)
2.6 Japan Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029)
2.7 South Korea Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029)
2.8 ASEAN Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029)
2.9 India Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029)
3 WORLD ANTISENSE OLIGONUCLEOTIDES-BASED THERAPEUTICS COMPANIES COMPETITIVE ANALYSIS
3.1 World Antisense Oligonucleotides-based Therapeutics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Antisense Oligonucleotides-based Therapeutics Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Antisense Oligonucleotides-based Therapeutics in 2022
3.2.3 Global Concentration Ratios (CR8) for Antisense Oligonucleotides-based Therapeutics in 2022
3.3 Antisense Oligonucleotides-based Therapeutics Company Evaluation Quadrant
3.4 Antisense Oligonucleotides-based Therapeutics Market: Overall Company Footprint Analysis
3.4.1 Antisense Oligonucleotides-based Therapeutics Market: Region Footprint
3.4.2 Antisense Oligonucleotides-based Therapeutics Market: Company Product Type Footprint
3.4.3 Antisense Oligonucleotides-based Therapeutics Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Antisense Oligonucleotides-based Therapeutics Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Antisense Oligonucleotides-based Therapeutics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Antisense Oligonucleotides-based Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Antisense Oligonucleotides-based Therapeutics Consumption Value Comparison
4.2.1 United States VS China: Antisense Oligonucleotides-based Therapeutics Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Antisense Oligonucleotides-based Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Antisense Oligonucleotides-based Therapeutics Companies and Market Share, 2018-2023
4.3.1 United States Based Antisense Oligonucleotides-based Therapeutics Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Antisense Oligonucleotides-based Therapeutics Revenue, (2018-2023)
4.4 China Based Companies Antisense Oligonucleotides-based Therapeutics Revenue and Market Share, 2018-2023
4.4.1 China Based Antisense Oligonucleotides-based Therapeutics Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Antisense Oligonucleotides-based Therapeutics Revenue, (2018-2023)
4.5 Rest of World Based Antisense Oligonucleotides-based Therapeutics Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Antisense Oligonucleotides-based Therapeutics Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Antisense Oligonucleotides-based Therapeutics Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Antisense Oligonucleotides-based Therapeutics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 With Chemical Modification
5.2.2 Without Chemical Modification
5.3 Market Segment by Type
5.3.1 World Antisense Oligonucleotides-based Therapeutics Market Size by Type (2018-2023)
5.3.2 World Antisense Oligonucleotides-based Therapeutics Market Size by Type (2024-2029)
5.3.3 World Antisense Oligonucleotides-based Therapeutics Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Antisense Oligonucleotides-based Therapeutics Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Neuromuscular Diseases
6.2.2 hATTR
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Antisense Oligonucleotides-based Therapeutics Market Size by Application (2018-2023)
6.3.2 World Antisense Oligonucleotides-based Therapeutics Market Size by Application (2024-2029)
6.3.3 World Antisense Oligonucleotides-based Therapeutics Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sarepta Therapeutics
7.1.1 Sarepta Therapeutics Details
7.1.2 Sarepta Therapeutics Major Business
7.1.3 Sarepta Therapeutics Antisense Oligonucleotides-based Therapeutics Product and Services
7.1.4 Sarepta Therapeutics Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Sarepta Therapeutics Recent Developments/Updates
7.1.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.2 Ionis Pharmaceuticals
7.2.1 Ionis Pharmaceuticals Details
7.2.2 Ionis Pharmaceuticals Major Business
7.2.3 Ionis Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Product and Services
7.2.4 Ionis Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Ionis Pharmaceuticals Recent Developments/Updates
7.2.6 Ionis Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Biogen
7.3.1 Biogen Details
7.3.2 Biogen Major Business
7.3.3 Biogen Antisense Oligonucleotides-based Therapeutics Product and Services
7.3.4 Biogen Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Biogen Recent Developments/Updates
7.3.6 Biogen Competitive Strengths & Weaknesses
7.4 Nippon Shinyaku
7.4.1 Nippon Shinyaku Details
7.4.2 Nippon Shinyaku Major Business
7.4.3 Nippon Shinyaku Antisense Oligonucleotides-based Therapeutics Product and Services
7.4.4 Nippon Shinyaku Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Nippon Shinyaku Recent Developments/Updates
7.4.6 Nippon Shinyaku Competitive Strengths & Weaknesses
7.5 Sobi
7.5.1 Sobi Details
7.5.2 Sobi Major Business
7.5.3 Sobi Antisense Oligonucleotides-based Therapeutics Product and Services
7.5.4 Sobi Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Sobi Recent Developments/Updates
7.5.6 Sobi Competitive Strengths & Weaknesses
7.6 Jazz Pharmaceuticals
7.6.1 Jazz Pharmaceuticals Details
7.6.2 Jazz Pharmaceuticals Major Business
7.6.3 Jazz Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Product and Services
7.6.4 Jazz Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Jazz Pharmaceuticals Recent Developments/Updates
7.6.6 Jazz Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Antisense Oligonucleotides-based Therapeutics Industry Chain
8.2 Antisense Oligonucleotides-based Therapeutics Upstream Analysis
8.3 Antisense Oligonucleotides-based Therapeutics Midstream Analysis
8.4 Antisense Oligonucleotides-based Therapeutics Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Antisense Oligonucleotides-based Therapeutics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Antisense Oligonucleotides-based Therapeutics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Antisense Oligonucleotides-based Therapeutics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Antisense Oligonucleotides-based Therapeutics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Antisense Oligonucleotides-based Therapeutics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Antisense Oligonucleotides-based Therapeutics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Antisense Oligonucleotides-based Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Antisense Oligonucleotides-based Therapeutics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Antisense Oligonucleotides-based Therapeutics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Antisense Oligonucleotides-based Therapeutics Players in 2022
Table 12. World Antisense Oligonucleotides-based Therapeutics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Antisense Oligonucleotides-based Therapeutics Company Evaluation Quadrant
Table 14. Head Office of Key Antisense Oligonucleotides-based Therapeutics Player
Table 15. Antisense Oligonucleotides-based Therapeutics Market: Company Product Type Footprint
Table 16. Antisense Oligonucleotides-based Therapeutics Market: Company Product Application Footprint
Table 17. Antisense Oligonucleotides-based Therapeutics Mergers & Acquisitions Activity
Table 18. United States VS China Antisense Oligonucleotides-based Therapeutics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Antisense Oligonucleotides-based Therapeutics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Antisense Oligonucleotides-based Therapeutics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Antisense Oligonucleotides-based Therapeutics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Antisense Oligonucleotides-based Therapeutics Revenue Market Share (2018-2023)
Table 23. China Based Antisense Oligonucleotides-based Therapeutics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Antisense Oligonucleotides-based Therapeutics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Antisense Oligonucleotides-based Therapeutics Revenue Market Share (2018-2023)
Table 26. Rest of World Based Antisense Oligonucleotides-based Therapeutics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Antisense Oligonucleotides-based Therapeutics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Antisense Oligonucleotides-based Therapeutics Revenue Market Share (2018-2023)
Table 29. World Antisense Oligonucleotides-based Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Antisense Oligonucleotides-based Therapeutics Market Size by Type (2018-2023) & (USD Million)
Table 31. World Antisense Oligonucleotides-based Therapeutics Market Size by Type (2024-2029) & (USD Million)
Table 32. World Antisense Oligonucleotides-based Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Antisense Oligonucleotides-based Therapeutics Market Size by Application (2018-2023) & (USD Million)
Table 34. World Antisense Oligonucleotides-based Therapeutics Market Size by Application (2024-2029) & (USD Million)
Table 35. Sarepta Therapeutics Basic Information, Area Served and Competitors
Table 36. Sarepta Therapeutics Major Business
Table 37. Sarepta Therapeutics Antisense Oligonucleotides-based Therapeutics Product and Services
Table 38. Sarepta Therapeutics Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Sarepta Therapeutics Recent Developments/Updates
Table 40. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 41. Ionis Pharmaceuticals Basic Information, Area Served and Competitors
Table 42. Ionis Pharmaceuticals Major Business
Table 43. Ionis Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Product and Services
Table 44. Ionis Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Ionis Pharmaceuticals Recent Developments/Updates
Table 46. Ionis Pharmaceuticals Competitive Strengths & Weaknesses
Table 47. Biogen Basic Information, Area Served and Competitors
Table 48. Biogen Major Business
Table 49. Biogen Antisense Oligonucleotides-based Therapeutics Product and Services
Table 50. Biogen Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Biogen Recent Developments/Updates
Table 52. Biogen Competitive Strengths & Weaknesses
Table 53. Nippon Shinyaku Basic Information, Area Served and Competitors
Table 54. Nippon Shinyaku Major Business
Table 55. Nippon Shinyaku Antisense Oligonucleotides-based Therapeutics Product and Services
Table 56. Nippon Shinyaku Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Nippon Shinyaku Recent Developments/Updates
Table 58. Nippon Shinyaku Competitive Strengths & Weaknesses
Table 59. Sobi Basic Information, Area Served and Competitors
Table 60. Sobi Major Business
Table 61. Sobi Antisense Oligonucleotides-based Therapeutics Product and Services
Table 62. Sobi Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Sobi Recent Developments/Updates
Table 64. Jazz Pharmaceuticals Basic Information, Area Served and Competitors
Table 65. Jazz Pharmaceuticals Major Business
Table 66. Jazz Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Product and Services
Table 67. Jazz Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 68. Global Key Players of Antisense Oligonucleotides-based Therapeutics Upstream (Raw Materials)
Table 69. Antisense Oligonucleotides-based Therapeutics Typical Customers
LIST OF FIGURE
Figure 1. Antisense Oligonucleotides-based Therapeutics Picture
Figure 2. World Antisense Oligonucleotides-based Therapeutics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Antisense Oligonucleotides-based Therapeutics Total Market Size (2018-2029) & (USD Million)
Figure 4. World Antisense Oligonucleotides-based Therapeutics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Antisense Oligonucleotides-based Therapeutics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Antisense Oligonucleotides-based Therapeutics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Antisense Oligonucleotides-based Therapeutics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Antisense Oligonucleotides-based Therapeutics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Antisense Oligonucleotides-based Therapeutics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Antisense Oligonucleotides-based Therapeutics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Antisense Oligonucleotides-based Therapeutics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Antisense Oligonucleotides-based Therapeutics Revenue (2018-2029) & (USD Million)
Figure 13. Antisense Oligonucleotides-based Therapeutics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 16. World Antisense Oligonucleotides-based Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 18. China Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 23. India Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Antisense Oligonucleotides-based Therapeutics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Antisense Oligonucleotides-based Therapeutics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Antisense Oligonucleotides-based Therapeutics Markets in 2022
Figure 27. United States VS China: Antisense Oligonucleotides-based Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Antisense Oligonucleotides-based Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Antisense Oligonucleotides-based Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Antisense Oligonucleotides-based Therapeutics Market Size Market Share by Type in 2022
Figure 31. With Chemical Modification
Figure 32. Without Chemical Modification
Figure 33. World Antisense Oligonucleotides-based Therapeutics Market Size Market Share by Type (2018-2029)
Figure 34. World Antisense Oligonucleotides-based Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Antisense Oligonucleotides-based Therapeutics Market Size Market Share by Application in 2022
Figure 36. Neuromuscular Diseases
Figure 37. hATTR
Figure 38. Other
Figure 39. Antisense Oligonucleotides-based Therapeutics Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Table 1. World Antisense Oligonucleotides-based Therapeutics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Antisense Oligonucleotides-based Therapeutics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Antisense Oligonucleotides-based Therapeutics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Antisense Oligonucleotides-based Therapeutics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Antisense Oligonucleotides-based Therapeutics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Antisense Oligonucleotides-based Therapeutics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Antisense Oligonucleotides-based Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Antisense Oligonucleotides-based Therapeutics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Antisense Oligonucleotides-based Therapeutics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Antisense Oligonucleotides-based Therapeutics Players in 2022
Table 12. World Antisense Oligonucleotides-based Therapeutics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Antisense Oligonucleotides-based Therapeutics Company Evaluation Quadrant
Table 14. Head Office of Key Antisense Oligonucleotides-based Therapeutics Player
Table 15. Antisense Oligonucleotides-based Therapeutics Market: Company Product Type Footprint
Table 16. Antisense Oligonucleotides-based Therapeutics Market: Company Product Application Footprint
Table 17. Antisense Oligonucleotides-based Therapeutics Mergers & Acquisitions Activity
Table 18. United States VS China Antisense Oligonucleotides-based Therapeutics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Antisense Oligonucleotides-based Therapeutics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Antisense Oligonucleotides-based Therapeutics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Antisense Oligonucleotides-based Therapeutics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Antisense Oligonucleotides-based Therapeutics Revenue Market Share (2018-2023)
Table 23. China Based Antisense Oligonucleotides-based Therapeutics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Antisense Oligonucleotides-based Therapeutics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Antisense Oligonucleotides-based Therapeutics Revenue Market Share (2018-2023)
Table 26. Rest of World Based Antisense Oligonucleotides-based Therapeutics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Antisense Oligonucleotides-based Therapeutics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Antisense Oligonucleotides-based Therapeutics Revenue Market Share (2018-2023)
Table 29. World Antisense Oligonucleotides-based Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Antisense Oligonucleotides-based Therapeutics Market Size by Type (2018-2023) & (USD Million)
Table 31. World Antisense Oligonucleotides-based Therapeutics Market Size by Type (2024-2029) & (USD Million)
Table 32. World Antisense Oligonucleotides-based Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Antisense Oligonucleotides-based Therapeutics Market Size by Application (2018-2023) & (USD Million)
Table 34. World Antisense Oligonucleotides-based Therapeutics Market Size by Application (2024-2029) & (USD Million)
Table 35. Sarepta Therapeutics Basic Information, Area Served and Competitors
Table 36. Sarepta Therapeutics Major Business
Table 37. Sarepta Therapeutics Antisense Oligonucleotides-based Therapeutics Product and Services
Table 38. Sarepta Therapeutics Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Sarepta Therapeutics Recent Developments/Updates
Table 40. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 41. Ionis Pharmaceuticals Basic Information, Area Served and Competitors
Table 42. Ionis Pharmaceuticals Major Business
Table 43. Ionis Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Product and Services
Table 44. Ionis Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Ionis Pharmaceuticals Recent Developments/Updates
Table 46. Ionis Pharmaceuticals Competitive Strengths & Weaknesses
Table 47. Biogen Basic Information, Area Served and Competitors
Table 48. Biogen Major Business
Table 49. Biogen Antisense Oligonucleotides-based Therapeutics Product and Services
Table 50. Biogen Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Biogen Recent Developments/Updates
Table 52. Biogen Competitive Strengths & Weaknesses
Table 53. Nippon Shinyaku Basic Information, Area Served and Competitors
Table 54. Nippon Shinyaku Major Business
Table 55. Nippon Shinyaku Antisense Oligonucleotides-based Therapeutics Product and Services
Table 56. Nippon Shinyaku Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Nippon Shinyaku Recent Developments/Updates
Table 58. Nippon Shinyaku Competitive Strengths & Weaknesses
Table 59. Sobi Basic Information, Area Served and Competitors
Table 60. Sobi Major Business
Table 61. Sobi Antisense Oligonucleotides-based Therapeutics Product and Services
Table 62. Sobi Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Sobi Recent Developments/Updates
Table 64. Jazz Pharmaceuticals Basic Information, Area Served and Competitors
Table 65. Jazz Pharmaceuticals Major Business
Table 66. Jazz Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Product and Services
Table 67. Jazz Pharmaceuticals Antisense Oligonucleotides-based Therapeutics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 68. Global Key Players of Antisense Oligonucleotides-based Therapeutics Upstream (Raw Materials)
Table 69. Antisense Oligonucleotides-based Therapeutics Typical Customers
LIST OF FIGURE
Figure 1. Antisense Oligonucleotides-based Therapeutics Picture
Figure 2. World Antisense Oligonucleotides-based Therapeutics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Antisense Oligonucleotides-based Therapeutics Total Market Size (2018-2029) & (USD Million)
Figure 4. World Antisense Oligonucleotides-based Therapeutics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Antisense Oligonucleotides-based Therapeutics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Antisense Oligonucleotides-based Therapeutics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Antisense Oligonucleotides-based Therapeutics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Antisense Oligonucleotides-based Therapeutics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Antisense Oligonucleotides-based Therapeutics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Antisense Oligonucleotides-based Therapeutics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Antisense Oligonucleotides-based Therapeutics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Antisense Oligonucleotides-based Therapeutics Revenue (2018-2029) & (USD Million)
Figure 13. Antisense Oligonucleotides-based Therapeutics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 16. World Antisense Oligonucleotides-based Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 18. China Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 23. India Antisense Oligonucleotides-based Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Antisense Oligonucleotides-based Therapeutics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Antisense Oligonucleotides-based Therapeutics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Antisense Oligonucleotides-based Therapeutics Markets in 2022
Figure 27. United States VS China: Antisense Oligonucleotides-based Therapeutics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Antisense Oligonucleotides-based Therapeutics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Antisense Oligonucleotides-based Therapeutics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Antisense Oligonucleotides-based Therapeutics Market Size Market Share by Type in 2022
Figure 31. With Chemical Modification
Figure 32. Without Chemical Modification
Figure 33. World Antisense Oligonucleotides-based Therapeutics Market Size Market Share by Type (2018-2029)
Figure 34. World Antisense Oligonucleotides-based Therapeutics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Antisense Oligonucleotides-based Therapeutics Market Size Market Share by Application in 2022
Figure 36. Neuromuscular Diseases
Figure 37. hATTR
Figure 38. Other
Figure 39. Antisense Oligonucleotides-based Therapeutics Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
